{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:24:54Z","timestamp":1785536694083,"version":"3.56.0"},"reference-count":49,"publisher":"National Academy of Sciences","issue":"50","license":[{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1177824"],"award-info":[{"award-number":["OPP1177824"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1184344"],"award-info":[{"award-number":["OPP1184344"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1156227"],"award-info":[{"award-number":["OPP1156227"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1186851"],"award-info":[{"award-number":["OPP1186851"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2021,12,14]]},"abstract":"<jats:title>Significance<\/jats:title>\n                  <jats:p>While the health economic implications of disease elimination have been discussed before, the combination of uncertainty, cost effectiveness, and elimination has not been tackled before. We propose a modification to the net-benefit framework to explicitly consider the implications of switching from an optimal strategy, in terms of cost-per-burden averted, to a strategy with a higher likelihood of meeting the global target of elimination. The modification proposed yields a methodology to quantify the efficiency of elimination and to aid discussions among stakeholders with different objectives. We apply our method to strategies against human African trypanosomiasis in three settings, but this method is flexible enough that it can be applied directly to any simulation-based studies of disease elimination efforts.<\/jats:p>","DOI":"10.1073\/pnas.2026797118","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T17:35:25Z","timestamp":1639071325000},"update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":10,"title":["Economic evaluation of disease elimination: An extension to the net-benefit framework and application to human African trypanosomiasis"],"prefix":"10.1073","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0235-6030","authenticated-orcid":false,"given":"Marina","family":"Antillon","sequence":"first","affiliation":[{"name":"Epidemiology and Public Health, Swiss Tropical and Public Health Institute, 4123 Allschwil, Switzerland;"},{"name":"University of Basel, 4001 Basel, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8329-8310","authenticated-orcid":false,"given":"Ching-I","family":"Huang","sequence":"additional","affiliation":[{"name":"Zeeman Institute, University of Warwick, Coventry CV4 7AL, United Kingdom;"},{"name":"Mathematics Institute, University of Warwick, Coventry CV4 7AL, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8414-7648","authenticated-orcid":false,"given":"Kat S.","family":"Rock","sequence":"additional","affiliation":[{"name":"Zeeman Institute, University of Warwick, Coventry CV4 7AL, United Kingdom;"},{"name":"Mathematics Institute, University of Warwick, Coventry CV4 7AL, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8671-9400","authenticated-orcid":false,"given":"Fabrizio","family":"Tediosi","sequence":"additional","affiliation":[{"name":"Epidemiology and Public Health, Swiss Tropical and Public Health Institute, 4123 Allschwil, Switzerland;"},{"name":"University of Basel, 4001 Basel, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2021,12,9]]},"reference":[{"key":"e_1_3_4_1_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005759"},{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-017-0288-0"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2012.0149"},{"key":"e_1_3_4_4_2","unstructured":"World Health Organization Global Wild Poliovirus 2016-2021 (2021). https:\/\/polioeradication.org\/wp-content\/uploads\/2021\/02\/weekly-polio-analyses-WPV-20210216.pdf. Accessed 21 April 2021."},{"key":"e_1_3_4_5_2","first-page":"561","article-title":"Projection of costs of polio eradication compared to permanent control","volume":"221","author":"Zimmermann M.","year":"2020","unstructured":"M. Zimmermann, B. Hagedorn, H. Lyons, Projection of costs of polio eradication compared to permanent control. J. Infect. Dis. 221, 561\u2013565 (2020).","journal-title":"J. Infect. Dis."},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005922"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-019-02921-w"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2019-001633"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.10.009"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1101694108"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1098\/rsif.2015.0907"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.epidem.2015.11.002"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1596\/978-1-4648-0527-1_ch8"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X98018002S09"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/hec.635"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.14.138206"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1744133116000049"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.02.017"},{"key":"e_1_3_4_19_2","doi-asserted-by":"crossref","first-page":"e000964","DOI":"10.1136\/bmjgh-2018-000964","article-title":"Estimating health opportunity costs in low-income and middle-income countries: A novel approach and evidence from cross-country data","volume":"3","author":"Ochalek J.","year":"2018","unstructured":"J. Ochalek, J. Lomas, K. Claxton, Estimating health opportunity costs in low-income and middle-income countries: A novel approach and evidence from cross-country data. BMJ Glob. Heal. 3, e000964 (2018).","journal-title":"BMJ Glob. Heal."},{"key":"e_1_3_4_20_2","volume-title":"Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis.","author":"World Health Organization","year":"2003","unstructured":"World Health Organization, Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis. (WHO, Geneva, Switzerland, 2003)."},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X9701700414"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200017050-00006"},{"key":"e_1_3_4_23_2","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198526629.001.0001","volume-title":"Decision Modelling for Health Economic Evaluation","author":"Briggs A.","year":"2006","unstructured":"A. Briggs, K. Claxton, M. Sculpher, Decision Modelling for Health Economic Evaluation (Oxford University Press, Oxford, UK, ed. 1, 2006).","edition":"1"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462314000671"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czaa073"},{"key":"e_1_3_4_26_2","volume-title":"WHO Interim Guidelines for the Treatment of Gambiense Human African Trypanosomiasis","author":"World Health Organization","year":"2019","unstructured":"World Health Organization, WHO Interim Guidelines for the Treatment of Gambiense Human African Trypanosomiasis (WHO, 2019)."},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003822"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003727"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005792"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/hec.4730030505"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/1099-1050(200010)9:7<623::AID-HEC539>3.0.CO;2-V"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2014.302454"},{"key":"e_1_3_4_33_2","first-page":"71","article-title":"The zero-sum goal","volume":"23","author":"Aylward B.","year":"2001","unstructured":"B. Aylward, The zero-sum goal. Harvard Int. Rev. 23, 71\u201375 (2001).","journal-title":"Harvard Int. Rev."},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1596\/978-1-4648-0524-0_ch17"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.275.5296.65"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1890\/0012-9615(2002)072[0185:DOMESN]2.0.CO;2"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074696"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X15583266"},{"key":"e_1_3_4_39_2","first-page":"275","article-title":"Ethical considerations for global health decision-making: Justice-enhanced cost-effectiveness analysis of new technologies for Trypanosoma brucei gambiense","volume":"11","author":"Merritt M. W.","year":"2018","unstructured":"M. W. Merritt, C. S. Sutherland, F. Tediosi, Ethical considerations for global health decision-making: Justice-enhanced cost-effectiveness analysis of new technologies for Trypanosoma brucei gambiense. Public Health Ethics 11, 275\u2013292 (2018).","journal-title":"Public Health Ethics"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/hec.3019"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)06088-6"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001246"},{"key":"e_1_3_4_43_2","unstructured":"WHO Expert Committee on Human African Trypanosomiasis \u201cControl and surveillance of human African trypanosomiasis: Report of a WHO expert committee\u201d (Tech. Rep. no. 984 World Health Organization Geneva Switzerland 2013)."},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008261"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1008532"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1186\/1476-072X-9-57"},{"key":"e_1_3_4_47_2","doi-asserted-by":"crossref","unstructured":"C. I. Huang . Identifying regions for enhanced control of gambiense sleeping sickness in the Democratic Republic of Congo. medRxiv [Preprint] (2020). https:\/\/doi.org\/10.1101\/2020.07.03.20145847 (Accessed 30 November 2020).","DOI":"10.1101\/2020.07.03.20145847"},{"key":"e_1_3_4_48_2","doi-asserted-by":"crossref","unstructured":"M. Antillon . Cost-effectiveness of sleeping sickness elimination campaigns in five settings of the Democratic Republic of Congo. medRxiv [Preprint] (2020). https:\/\/doi.org\/10.1101\/2021.02.10.20181974 (Accessed 30 November 2020).","DOI":"10.1101\/2020.08.25.20181982"},{"key":"e_1_3_4_49_2","unstructured":"M. Antillon . HATMEPP and NTD Modelling Consortium\/FW_3HZ. Open Science Framework. https:\/\/doi.org\/10.17605\/OSF.IO\/FH6CA. Deposited 28 June 2021."}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.pnas.org\/syndication\/doi\/10.1073\/pnas.2026797118","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.2026797118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T17:10:07Z","timestamp":1699895407000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.2026797118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,9]]},"references-count":49,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2021,12,14]]}},"alternative-id":["10.1073\/pnas.2026797118"],"URL":"https:\/\/doi.org\/10.1073\/pnas.2026797118","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.02.10.20181974","asserted-by":"object"}]},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,9]]},"assertion":[{"value":"2021-10-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2026797118"}}